Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2.63M Sell
11,686
-854
-7% -$180K 1.52% 27
2021
Q3
$2.67M Sell
12,540
-380
-3% -$87.5K 1.56% 29
2021
Q2
$3.15M Buy
12,920
+100
+0.8% +$24.6K 1.83% 24
2021
Q1
$3.19M Sell
12,820
-100
-0.8% -$23.9K 1.99% 22
2020
Q4
$2.97M Hold
12,920
2% 22
2020
Q3
$3.28M Hold
12,920
2.54% 13
2020
Q2
$3.05M Hold
12,920
2.6% 12
2020
Q1
$2.62M Sell
12,920
-5,987
-32% -$1.31M 2.81% 10
2019
Q4
$4.56M Sell
18,907
-398
-2% -$87.7K 2.55% 11
2019
Q3
$3.73M Sell
19,305
-60
-0.3% -$11.5K 2.18% 18
2019
Q2
$3.57M Hold
19,365
2.06% 21
2019
Q1
$3.68M Hold
19,365
2.21% 19
2018
Q4
$3.77M Sell
19,365
-600
-3% -$117K 2.57% 19
2018
Q3
$4.14M Sell
19,965
-260
-1% -$51.2K 2.26% 20
2018
Q2
$3.73M Buy
20,225
+178
+0.9% +$31.5K 2.07% 25
2018
Q1
$3.42M Hold
20,047
1.88% 30
2017
Q4
$3.49M Sell
20,047
-100
-0.5% -$17.7K 1.87% 27
2017
Q3
$3.76M Sell
20,147
-253
-1% -$44.8K 2.11% 26
2017
Q2
$3.51M Hold
20,400
2.08% 25
2017
Q1
$3.35M Sell
20,400
-3,900
-16% -$648K 2% 22
2016
Q4
$3.55M Buy
24,300
+400
+2% +$60.2K 2.27% 16
2016
Q3
$3.99M Sell
23,900
-8,500
-26% -$1.44M 2.62% 13
2016
Q2
$4.93M Sell
32,400
-2,283
-7% -$355K 3.36% 7
2016
Q1
$5.2M Sell
34,683
-4,100
-11% -$609K 3.55% 6
2015
Q4
$6.3M Sell
38,783
-3,400
-8% -$534K 4.11% 1
2015
Q3
$5.83M Hold
42,183
3.69% 3
2015
Q2
$6.47M Sell
42,183
-17
-0% -$2.72K 3.61% 6
2015
Q1
$6.75M Sell
42,200
-1,800
-4% -$283K 3.79% 3
2014
Q4
$7.01M Sell
44,000
-1,800
-4% -$280K 3.89% 1
2014
Q3
$6.43M Sell
45,800
-3,000
-6% -$392K 3.71% 2
2014
Q2
$5.78M Buy
48,800
+800
+2% +$92.6K 3.33% 3
2014
Q1
$5.92M Buy
48,000
+100
+0.2% +$12.1K 3.59% 2
2013
Q4
$5.46M Sell
47,900
-100
-0.2% -$11.4K 3.44% 2
2013
Q3
$5.37M Sell
48,000
-100
-0.2% -$10.8K 3.73% 2
2013
Q2
$4.75M Buy
+48,100
New +$4.99M 3.4% 5

Other funds holding AMGN

MRJ Capital's AMGN Position: Q4 2021 in Review

MRJ Capital reduced its Amgen (AMGN) stake by 6.8% in Q4 2021, selling an estimated $180K and leaving 11,686 shares worth $2.63M. The position accounts for 1.52% of the portfolio, ranked #27.

MRJ Capital first reported a position in AMGN in Q2 2013 and has held it in 35 quarters since. The position peaked at $7.01M in Q4 2014. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • MRJ Capital held 11,686 shares of Amgen worth $2.63M as of Q4 2021.
  • MRJ Capital sold 854 Amgen shares in Q4 2021, an estimated $180K.
  • Amgen made up 1.52% of MRJ Capital's portfolio in Q4 2021, its #27 holding.
  • MRJ Capital first reported a position in Amgen in Q2 2013 and has held it in 35 quarters since.
  • MRJ Capital's Amgen position peaked at $7.01M in Q4 2014.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on MRJ Capital's 13F filing for Q4 2021, filed 25 Jan 2022.